Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Àlvaro Quintanal-Villalonga(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center)
Cited by 92
Related Papers
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
|New England Journal of Medicine|2009|1k
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
|Frontiers in Oncology|2020|112
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
|Journal of Thoracic Oncology|2019|71
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
|Science Translational Medicine|2023|44
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
|Journal of Thoracic Oncology|2022|35